최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기응용통계연구 = The Korean journal of applied statistics, v.35 no.2, 2022년, pp.251 - 263
전소영 (가톨릭대학교 의생명.건강과학과) , 김동재 (가톨릭대학교 의생명.건강과학과)
Phase I clinical trial is called 'Dose finding study'. It is first step of experimenting on humans with new drugs developed through animal experiments or vitro experiments. The important area of interest in designing Phase I clinical trial is determining the dose that acceptable level to the patient...
Ahn C (1998). An evaluation of phase I cancer clinical trial designs, Statistics in Medicine, 17, 1537-1549.
Dixon WJ and Mode AM (1948). A method for obtaining and analyzing sensitivity data, Journal of the American Statistical Association, 43, 109-128.
Efron B (1971). Forcing a sequential experiment to be balanced, Biometrika, 58, 403-417.
Goodman SN, Zahurak ML, and Piantadosi S (1995). Some practical improvements in the continual reassessment method for phase I studies, Statistics in Medicine, 14, 1149-1161.
Korn EL, Midthune D, Chen TT, Rubinstein LV, Christian MC, and Simon RM (1994). A comparison of two phase I trail designs, Statistics in Medicine, 13, 1799-1806.
O'Quigley J and Chevret S (1991). Method for dose finding studies in cancer clinical trials: a review and results of a Monte Carlo study, Statistics in Medicine, 10, 1647-1664.
Park I (1999). The estimation of maximal tolerated dose in sequential phase I clinical trials (Master's Thesis of Science), The Catholic University of Korea.
Storer BE (1989). Design and analysis of phase I clinical trials, Biometrics, 45, 925-937.
Storer BE (2001). An evaluation of phase I clinical trial designs in the continuous dose response setting, Statistics in Medicine, 20, 2399-2408.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.